The latest news on the fight to end viral hepatitis.
News
For media enquiries, contact: admin@endhep2030.org
Press Releases
The Hepatitis Fund and the Clinton Health Access Initiative announce high-level donor mobilization conference to eliminate viral hepatitis to be held in Geneva, Switzerland, on 17 May 2023
Call for Proposals to Accelerate Action to Eliminate Viral Hepatitis
The Fund for Elimination of Viral Hepatitis (DBA "EndHep2030") announces a Call for Proposals for its inaugural set of grants (March 8, 2019. San Francisco, U.S.) EndHep2030 seeks partners with innovative approaches for accelerating the elimination of viral hepatitis. A complete list of eligibility requirements, selection criteria, and additional details regarding the application process are available at www.endhep2030.org/grants.
Dedicated fund is launched for global campaign to eliminate viral hepatitis.
The Fund for Elimination of Viral Hepatitis (DBA "EndHep2030") has been launched at the World Hepatitis Summit (November 1-3, 2017. Sao Paulo, Brazil). Conceived as a collaborative funding platform, EndHep2030 was a direct outcome of the International Roundtable Summit of Funding for Elimination of Viral Hepatitis (June 20-21, 2016. Hong Kong, China).
International Roundtable Summit on Funding for Elimination of Viral Hepatitis
In June 2016 ZeShan Foundation, in collaboration with the United States Centers for Disease Control and Prevention (US CDC) and the World Health Organization (WHO), convened a meeting designed to stimulate critical thinking and discussion around the establishment of an international funding mechanism to support the implementation of the Global Health Sector Strategy on Viral Hepatitis (“WHO Global Hepatitis Strategy”).
About EndHep2030
Global Hepatitis Resource Mobilization Conference – Media Coverage
Viral Hepatitis Deaths Projected to Exceed HIV, TB, and Malaria Combined by 2040
Pledging conference But funding to help poor countries pay for the treatments and vaccines to cure and eliminate this debilitating disease remains elusive. To address this issue, the Hepatitis Fund and CHAI will hold the first-ever pledging conference in Geneva next week. The conference hopes to raise $150 million to support countries that are committed[…..]
Global Priority Statement: Integrate Hepatitis B Responses into Harm Reduction
The Viral Hepatitis Pre-Conference, as part of the Harm Reduction International 2023 Conference #HR23 is calling for action to integrate Hepatitis B responses into harm reduction. Join us in ensuring that every person who inject drug has the right to be protected from Hepatitis B infection and has access to the care they need.
Hepatitis Fund aims to accelerate viral hepatitis elimination
The Lancet - Hepatitis Fund aims to accelerate viral hepatitis elimination
Handling of Hepatitis Not Integrated
Handling of Hepatitis Not Integrated – FULL ARTICLE HERE Hepatitis is still claiming many lives globally, and limited access to examination and treatment services remains a significant obstacle to controlling the disease. In Indonesia, collaborations between different parties have led to the implementation of hepatitis prevention programmes. However, THF’s Director of Programme and Partnerships Capucine Pénicaud ,[…..]
EndHep2030 relocates to Geneva
Funding the elimination of viral hepatitis: donors needed
Lancet, December 2017
Fondo global para financiar la eliminación de la hepatitis viral
Hepatitis2000, February 2019
In the News
HIV and Hepatitis Integration at ICASA 2023
ICASA 2023, the 22nd edition of the largest conference on HIV/AIDS in Africa, will take place from 4 to 9 December in Harare, Zimbabwe. On Thursday, 7 December 2023, we will join a Satellite Session we co-organised with the Society for AIDS in Africa, the WHO, and the Clinton Health Access Initiative (CHAI) on HIV[…..]
Connecting the Dots: A Vital Step in APAC Liver Health
The month of October marks Liver Cancer Awareness Month and serves as an essential reminder to spread awareness about the risks, prevention, and early detection of the disease, which is the third most common cause of cancer deaths worldwide. A silent yet major contributor to liver cancer is viral hepatitis. Chronic viral hepatitis can progress[…..]
THF at the African Hepatitis Summit 2023
From 24 to 26 October 2023, we’ll be in Abuja, Nigeria, for the third Africa Hepatitis Summit. The conference will bring civil society organizations, policymakers, global funders, medical professionals, and other stakeholders under the theme “Putting Africa on Track towards Viral Hepatitis Elimination”. Confirmed conference speakers include our Executive Director, Finn Jarle Rode, and our[…..]
INHSU 2023 – The 11th International Conference on Health and Hepatitis in Substance Users
From 18 to 20 October 2023, we’ll be at INHSU 2023 in Geneva. Hosted by INHSU – the International Network on Health and Hepatitis in Substance Users – the conference will bring together over 800 people from over 50 countries working in the fields of harm reduction, infectious diseases, drug policy and more. Co-conveners of[…..]
APAC Liver Disease Alliance White Paper launch
On 18 July at 9 AM CEST/3 PM SGT, our Partnerships and Programme Director, Capucine Pénicaud, will join an expert panel for the online launch of the first White Paper of APAC Liver Disease Alliance with the title “Eliminating Asia’s Silent Emergency: Hepatitis and Hepatocellular Carcinoma”. The APAC Liver Disease Alliance was officially launched in January 2023.[…..]
THF at the Africa Health ExCon
From 6 to 9 June, we will be in Cairo at the Africa Health ExCon, the largest Medical Conferences and Exhibition in Africa. On Wednesday, 7 June, our Executive Director, Finn Jarle Rode, will chair the “Investors and Funders for International Cooperation – Resources and Lessons from the Pandemic” session with speakers from the African[…..]
THF at the Global Hepatitis Summit 2023
From 25 to 28 April 2023, we will be in Paris at the Global Hepatitis Summit 2023 (the 18th International Symposium on Viral Hepatitis and Liver Disease – ISVHLD). On Thursday, 27 April (8.30 – 10.30), our Senior Grant Manager, Maria Carolina Salazar, will join the WHO Symposium “Viral hepatitis elimination – What’s new, what’s[…..]
Statement: The Hepatitis Fund (THF) today warmly welcomed the announcement by Unitaid of US$ 31 million to fund three new consortia charged with working to more effective prevention of hepatitis C (HCV) infection amongst people who inject drugs and prisoners.
Nearly 40 per cent (six million) of people who inject drugs globally are currently living with hepatitis C. But less than 10 per cent of those who need it have accessed treatment. “We need creative programmes that are capable of reaching the most vulnerable with those drugs we know can cure the disease,” said Helen[…..]